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Wanted: Posters
Members of the Washington University
School of Medicine community gathered
at the sixth annual Research Training
Symposium and Poster Session held in
October at the School of Medicine’s Farrell
Learning and Teaching Center. The event
showcases basic, clinical and translational
research projects by junior faculty, fellows,
residents and training program students.
It is cosponsored by the Clinical Research
Training Center (CRTC) — a component
of the university’s Institute of Clinical
and Translational Sciences (ICTS) — and
the Office of Medical Student Research.
The ICTS is part of a national consortium
of medical research institutions working
together to improve the way biomedical
research is conducted across the country.

Stay connected
View enhanced content online:
outlook.wustl.edu
Like the School of Medicine on Facebook:
facebook.com/WUSTLmedicine.health
Follow us on Twitter:
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fixing knees
S

ports medicine specialists at the School
of Medicine are leading a national study
analyzing why a second surgery to
reconstruct a tear in the knee’s anterior cruciate
ligament (ACL) carries a high risk of bad outcome.
More than 200,000 ACL reconstructions are
performed each year in the United States, and
1 percent to 8 percent fail for some reason. Most
patients then opt to have their knee ligament
reconstructed a second time, but the failure rate
on subsequent surgeries is nearly 14 percent.
The Washington University group received a
$2.6 million grant from the National Institute of
Arthritis and Musculoskeletal and Skin Diseases
and is leading dozens of surgeons across the
nation in one of the largest orthopedic, multicenter studies ever conducted: the MARS study
(Multicenter ACL Revision Study).
“If I reconstruct the ACL in your knee, and
you go back to sports, and three years later you
pivot on a basketball court and tear it again,
that subsequent surgery often does not have
results equal to the original surgery,” says Rick
W. Wright, MD, the Dr. Asa C. and Mrs. Dorothy
W. Jones Professor in Orthopaedic Surgery and
the MARS study’s principal investigator.
During ACL reconstruction, surgeons sometimes replace the torn knee ligament with a
ligament transplanted from a cadaver. In other
cases, the surgeon will move a piece of the
hamstring muscle or the patellar tendon and
attach it in place of the torn ligament.
Wright, who also is co-chief of Washington
University’s Sports Medicine Service and an
orthopedic surgeon at Barnes-Jewish Hospital,
and his colleagues are recruiting patients with
a second ACL tear for the MARS study. The
surgeons will note the condition of the knee
and how the original surgery was performed
to see whether that predicts problems with a
subsequent operation. They also will make note
of the surgical technique and source of the ACL
graft used in the initial reconstruction.
The surgeons will compare rehabilitation
techniques and whether particular approaches
are related to better or worse outcomes. Patients
will be surveyed about their knee function, the
general state of their health, and their quality of
life before and after a second ACL surgery.
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Second ACL repairs aren’t
always successful — why?

Although mostly a sports injury,
ACL tears — often caused by pivoting
or landing from a jump — can also
occur during rough play, motor
vehicle collisions, falls and
work-related injuries.

New diabetes research center
to focus on high-risk patients

DEPARTMENT OF ORTHOPAEDIC SURGERY

Washington University in St. Louis has received a five-year,
$3 million grant to establish a new center to develop better
ways to prevent and treat type 2 diabetes in high-risk patients,
including American Indians and Alaska Natives.
Funding for the Center for Diabetes Translation Research
comes from the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK) at the National Institutes of
Health (NIH). Washington University is one of seven institutions awarded funding to establish this type of center.
“The center is a unique opportunity to make sure cuttingedge science has an impact on real-world settings,” says Debra
Haire-Joshu, PhD, professor of public health at the university’s
Brown School and the School of Medicine and director of
the new center. “This grant will enable us to support research
that addresses the root causes of diabetes and disparities.”
Type 2 diabetes is the most
common form of diabetes,
• communication
according to the American
Diabetes Association. Millions of
• implementation
Americans have been diagnosed
• health policies
with high blood sugar — a hall• high-risk patients
mark of the disease — and many
more are at risk of the disease
F OUR CORES
because they are older, overweight or have a family history
of the disease. Left untreated,
high blood sugar can lead to complications such as eye,
nerve, kidney and heart damage.
American Indians and Alaska Natives have the highest
diabetes prevalence of all U.S. racial and ethnic groups,
according to the Centers for Disease Control and Prevention.
The two groups are twice as likely as white adults to suffer
from type 2 diabetes.
The center has four cores. The health communication and
health literacy core will evaluate the best ways to communicate information to improve diabetes prevention and care. A
second core will focus on how to translate research discoveries into better treatments and prevention. Another core will
address health and economic policy, and the fourth core will
support investigators working with American Indian and
Alaska Native communities.
The new center will serve as a resource for investigators at
Saint Louis University, the University of Missouri School of
Journalism, and the National Congress of American Indians.
“Our goal,” says Haire-Joshu, “is to significantly improve
the prevention and care of diabetes in populations at
increased risk of this devastating disease.”
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Grant to address disease, disparities

A glimpse of DNA Undergraduate students visiting
St. Louis for the Annual Biomedical Research Conference for
Minority Students examine slides of DNA at the Genome Institute.
The national conference, held in November, is designed to encourage
undergraduate, post-baccalaureate and graduate underrepresented
minority students to pursue advanced training in the biomedical
and behavioral sciences. Washington University, under the leadership
of its Division of Biology and Biomedical Sciences, hosted a visit for
about 200 students. At the School of Medicine, they toured the Hope
Center for Neurological Disorders, the Knight Alzheimer’s Disease
Research Center, the Center for Clinical Imaging Research, and the
BJC Institute of Health at Washington University School of Medicine.

PSA testing remains viable for some
A draft recommendation by the U.S. Preventive Services Task
Force calling for an end to routine PSA testing for healthy
men age 50 and older goes too far, says a prostate cancer
expert at the Alvin J. Siteman Cancer Center at Washington
University School of Medicine and Barnes-Jewish Hospital.
“Mass screening is not the way
to go,” says Gerald L. Andriole,
“Routine annual PSA screening
MD, chief of urologic surgery,
is not necessary for most men.
who acknowledges that wideBut men with a high risk of
spread testing has led many men
dying from prostate cancer —
with slow-growing tumors to be
particularly African Americans
overdiagnosed and overtreated.
and
those with a family history
“We have to take a more nuanced
of prostate cancer — should
approach to determine which men
still be screened.”
should be screened in the first place,
how frequently they should be
— Gerald L. Andriole, MD
tested, and whether their cancer
warrants therapy.”
Andriole, who also is the principal investigator of the
National Cancer Institute’s Prostate, Lung, Colorectal and
Ovarian (PLCO) screening trial, argues that it would be a
mistake to universally dismiss the PSA test. Rather, he says
the decision to screen should be left up to patients and their
doctors, who should take into consideration a man’s overall
health, age and other risk factors.
Outlook 3
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Kopan, Sibley named to Wolff
professorships in their fields
Honored for key medical research
Two leading members of the faculty have been named Alan
A. and Edith L. Wolff Professors in their respective fields.
Raphael Kopan, PhD, has been named the Wolff Professor of
Developmental Biology, and L. David Sibley, PhD, has been
named the Wolff Professor of Molecular Microbiology.
“Raphael Kopan’s research is revealing new details of how
an important protein guides the development of many of
the body’s tissues,” says Larry J. Shapiro, MD, executive vice
chancellor for medical affairs and
dean of the School of Medicine.
“David Sibley studies a common
parasite’s role in causing illness,
helping develop new insights into
its deadly microbial sibling, the
malaria parasite.”
Kopan joined Washington
University as an assistant professor
of medicine and of molecular
biology and pharmacology. He
studies a protein called Notch that
Raphael Kopan, PhD
is instrumental in guiding embryonic cells’ development into the body’s many tissue types.
Because Notch is present in so many cell types, Kopan’s
lab has contributed to medical research across an array of
disciplines, from Alzheimer’s disease to asthma to cancer.
Sibley was recruited as an assistant professor of molecular
microbiology and was promoted to full professor in 2002.
His lab focuses on Toxoplasma gondii, a parasite that may
infect as many as one in every four
humans. The parasite rarely causes
symptoms but can become a potentially life-threatening infection if
the immune system is weakened by
illnesses such as HIV or suppressed
to facilitate an organ transplant.
Sibley’s studies reveal how
Toxoplasma and its relatives,
including the malaria parasite
Plasmodium falciparum, infect
cells in the human body and
L. David Sibley, PhD
hence cause disease.
The late Alan and Edith Wolff supported medical research
at the School of Medicine for more than three decades. In
2007, Edith Wolff gave $20 million to Washington University
School of Medicine to establish the Alan A. and Edith L.
Wolff Institute, supporting biomedical research projects
leading to the prevention, treatment and cure of disease.
Winter 2011

Fresh faces

ROBERT BOSTON

Members of
the medical school Class of 2015
gathered in August at the School
of Medicine’s annual White Coat
Ceremony, at which they donned
their white coats — long a symbol
of the medical profession — and
recited a newly penned class oath.
Other programs, including the
Division of Biology and Biomedical
Sciences and the Programs in
Occupational Therapy, Physical
Therapy, and Audiology and
Communication Sciences, held
welcome celebrations that offered
students the opportunity to meet
one another as well as program
faculty and staff.

OPHTHALMOLOGY AND VISUAL SCIENCES

African-Americans’ risk for glaucoma

M

easuring oxygen during eye
surgery, investigators at the
School of Medicine have
discovered a potential explanation of why
African Americans have a higher risk of
glaucoma than Caucasians.
They found that oxygen levels are significantly higher in the eyes of African Americans
with glaucoma than in Caucasians with the
disease. The researchers, who reported their
findings in the July issue of the Archives of
Ophthalmology, suspect that more oxygen
may damage the eye’s drainage system,
resulting in elevated pressure that can
damage the optic nerve, causing blindness.
The study provides the first physiologic
clue about the link between race and risk for
glaucoma. Compared to Caucasians, glaucoma is about six times more common in
African Americans, and blindness caused by
glaucoma is roughly 16 times more likely.
“Our findings suggest there may be
physiologic differences in oxygen metabolism
between African Americans and Caucasians,”
says first author Carla J. Siegfried, MD. “In our
outlook.wustl.edu

studies, we were not looking specifically at
African Americans, but the racial difference in
oxygen levels was significant, and we believe
this observation deserves further study.”
Siegfried, professor of ophthalmology
and visual sciences, says it’s not surprising
that oxygen may play a big role in the development of glaucoma because it may be a
source of free radicals that damage cells. Like
cataracts, glaucoma is a disease associated
with aging. Oxidative stress, an imbalance
between these free radicals and antioxidants,
is linked to the aging process and many other
age-related conditions like cardiovascular and
neurodegenerative diseases.
“We began studying oxygen in the eye
after our basic studies showed that it was
tightly regulated there, with the lowest levels near the lens,” says David C. Beebe, PhD,
the Janet and Bernard Becker Professor of
Ophthalmology and Visual Sciences and
professor of cell biology and physiology.
“Clinical studies with Nancy Holekamp [MD,
professor of clinical ophthalmology and
visual sciences] and Ying-Bo Shui [MD, PhD,

Glaucoma is the
leading cause of
blindness among
African Americans.

senior scientist] revealed that exposure
of the lens to excess oxygen caused the
most common kind of cataracts. And our
discovery about cataracts led us, somewhat
surprisingly, to glaucoma. Dr. Siegfried
then joined us, confirming the connection between oxygen and glaucoma, and
the link between oxygen and race was yet
another surprise.”
Siegfried says it is not yet possible to say
whether the elevated oxygen levels cause
pressure to rise and optic nerve damage
to occur. Her team has received a four-year
grant from the National Eye Institute to
further investigate that association.
Outlook 5
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Hands-on health care

Mogboluwaga Oginni, left,
learns how to apply a cast from orthopedic technician Jamie Palmer
and April Nortrup, practice office manager of Orthopedic Tech
Services located in the Center for Advanced Medicine. Oginni, a
St. Louis University High School graduate now in his freshman year
at Creighton University, recently spent six weeks at the School of
Medicine as part of a paid internship program affiliated with the
East Central Missouri Area Health Education Center. An aspiring
physician, he was exposed to every aspect of Washington University
Orthopedics — from shadowing physicians as they repaired shattered
hips and dislocated shoulders to learning about patient billing.

Sanchez named Sicard professor

TIM PARKER

Luis A. Sanchez, MD, has been named the inaugural Gregorio
A. Sicard Distinguished Professor of Vascular Surgery.
Sanchez is highly regarded for his expertise in vascular
and endovascular surgery. He joined Washington University
in 1999 as an associate professor of surgery and radiology. In
2011, he was named chief of the section of vascular surgery at
the School of Medicine and Barnes-Jewish Hospital.
“Like Greg Sicard, Dr. Sanchez is an internationally known
innovator of endovascular surgery,” says Timothy J. Eberlein,
MD, the Bixby Professor and head of the Department of
Surgery, the Spencer T. and
Ann W. Olin Distinguished
Professor and director of
the Alvin J. Siteman Cancer
Center at Barnes-Jewish
Hospital and Washington
University School of
Medicine. “His contributions
have helped transform the
field. We are looking forward
to his leadership of our
Luis A. Sanchez, MD, left, and Gregorio A. Sicard, MD
program in vascular surgery
and keeping it the national leader that it is.”
Gregorio A. Sicard, MD, for whom the professorship is
named, is the Eugene M. Bricker Chair of Surgery at BarnesJewish Hospital. Sicard has spent his entire medical career at
Washington University, with numerous leadership roles in the
Department of Surgery. He is now the department’s executive
vice chairman.
6 Washington University School of Medicine

May yield diagnostic test for metastasis
Washington University in St. Louis has licensed to Castle
Biosciences Inc. the exclusive use of a gene to detect the
spread of cancer in melanoma patients.
A link between the BAP1 gene and cancer metastasis was
discovered by Washington University scientists J. William
Harbour, MD, an ophthalmologic oncologist, and Anne M.
Bowcock, PhD, a geneticist. Their research, published in 2010
in the journal Science, showed that BAP1 mutations occurred
in 84 percent of melanomas that developed in the eye and later
spread, but were rare in eye tumors that did not metastasize.
The researchers also have identified one individual with
a germline BAP1 mutation, indicating that this mutation
can be inherited and give
rise to a familial cancer
syndrome. Mutations in
the BAP1 gene have been
found in skin melanomas,
mesotheliomas, meningiomas and cancers of
the breast, ovary, kidney
and lung.
Harbour, the Paul
A. Cibis Distinguished
Professor of OphthalA cancerous melanoma tumor (dark area,
mology and Visual
upper right) is seen below the retina.
Sciences, and Bowcock,
professor of genetics, pediatrics and medicine, worked
closely with the university’s Office of Technology Management, which filed patents related to the BAP1 discovery,
giving the university the option to license the technology.
“This is a win-win situation for the university,” says
Bradley J. Castanho, PhD, director of the university’s Office
of Technology Management. “Licensing the technology
maximizes the opportunities for WUSTL scientists and the
university to take this discovery to the market, where it could
be developed into a diagnostic test for cancer metastasis.”
Castle Biosciences, based in Texas, is validating the BAP1
technology for use in both ocular melanoma and melanoma
that develops on the skin. The company plans to incorporate
BAP1 as a target in a clinical test for melanoma metastasis.
The new license is the second between the university and
Castle Biosciences for technology developed by Harbour. The
first exclusive license, in 2009, was related to technology to
predict the risk of metastasis in patients with ocular melanoma. The company has completed technical and clinical
validation studies, and the assay is now part of the standard
of care for patients with the disease.

HARBOUR LABORATORY

ROBERT BOSTON

Licensed gene linked to cancer
spread in melanoma patients

Winter 2011

Tread the Med is on the move
A new walking initiative sponsored by the School of
Medicine’s Wellness Committee attracted about 1,200
people to its official launch in September. Dean Larry J.
Shapiro, MD, left center, James P. Crane, MD, associate vice
chancellor for clinical affairs, right center, and Gregg

Evans, human resources consultant (not pictured), led the
group on a brief walk around Hudlin Park to kick off the
program. Designed to encourage members of the medical
school community to incorporate more walking into their
lives, thereby improving overall health, Tread the Med
boasts 118 teams with more than 2,000 participants.
more information

ROBERT BOSTON
ROBERT BOSTON
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ANESTHESIOLOGY

Preventing memory of surgery

A

nesthesiology researchers
have shown that a device
approved by the Food and Drug
Administration to reduce the risk that
patients will recall their surgery does not
lower the risk of the problem, known as
intraoperative awareness, any more than a
less expensive method.
The new study, published Aug. 18 in The
New England Journal of Medicine, involved
more than 6,000 surgical patients at
Washington University School of Medicine,
the University of Chicago and the University
of Manitoba in Winnipeg.
Unintended intraoperative awareness,
also known as anesthesia awareness, occurs
when a patient becomes aware during surgery and remembers being in pain or feeling distress during the operation. Between
one in 500 and one in 1,000 surgery
patients experience awareness during anesthesia. Those with such memories often
need psychological help, and some even
develop post-traumatic stress disorder.

outlook.wustl.edu

“We were testing whether a protocol
based on a device called a bispectral index
or BIS monitor, which measures brain
activity to determine how deeply a patient
is anesthetized, could more effectively
prevent intraoperative awareness than an
alternative approach that measures anesthetic levels in a patient’s breath,” says first
author Michael S. Avidan, MB, BCh,
professor of anesthesiology.
The study, called the international BIS
or Anesthetic Gas to Reduce Explicit Recall
(BAG-RECALL) trial, focused on a subset of
patients at high risk for awareness. They
include patients undergoing cardiac surgery, those who regularly consume large
amounts of alcohol or take sedatives or
certain types of pain-killing drugs. Patients
who previously have had episodes of
awareness also are at high risk.
Because the study showed that the
structured approach to using BIS monitoring is no better than one based on measuring exhaled anesthetics, Avidan and

Cheaper option is better

The bispectral index (BIS) monitor tracks brain activity.
co-investigator Alex S. Evers, MD, the Henry
E. Mallinckrodt Professor and head of the
Department of Anesthesiology, say the current, widespread use of the bispectral index
in operating rooms should be re-examined.
“New technology has to prove its superiority over more cost-effective alternatives,”
Avidan explains. “Our trial showed, compellingly, that the protocol based on the
bispectral index is not superior.”
Outlook 7

it takes
a team

Two minimally invasive techniques
in one procedure — an effective option
for a common heart arrhythmia

BY JULIA EVANGELOU STRAIT

8 Washington University School of Medicine

A S H E S AW E D A B AC K YA R D T R E E ,
Steve Gaal felt his heart start to race, and somehow it didn’t feel right. Over the next month he
experienced more of these worrisome episodes.
Sometimes the frantic beats stopped after a few
minutes; other times they lasted more than an hour.
“If I was walking up stairs when it started, I
could finish the staircase,” he says. “I could force
myself through it, but I felt like I shouldn’t do anything while it was happening. Most of the time, I
would just sit and wait for it to run its course.”
An active retiree, the former president and
CEO of Delta Dental of Missouri sought the advice
of his doctor, who referred him to a cardiologist. A
heart monitor revealed the problem — atrial fibrillation, the heart’s most common irregular beat.
Winter 2011

MARK GILLILAND

Pioneers in surgical techniques
for treating atrial fibrillation,
from left: Hersh S. Maniar, MD,
Ralph J. Damiano Jr., MD, Mitch
N. Faddis, MD, PhD, and Phillip S.
Cuculich, MD. Inset: Patient
Steve Gaal and his wife, Gina.

After standard treatments failed, Gaal’s doctors at the
School of Medicine suggested a new “hybrid” procedure. The
approach combines minimally invasive surgical techniques
with the latest advances in catheter ablation, a technique that
applies scars to the heart’s inner surface to block the signals
that cause the heart to misfire. The two-pronged approach
gives doctors access to both the inside and outside of the
heart at the same time, helping to more completely block the
erratic electrical signals that cause atrial fibrillation.
Atrial fibrillation affects more than 2 million Americans.
While not fatal in itself, patients who suffer from atrial fibrillation are at increased risk of stroke and congestive heart
failure. And many, especially those like Gaal who feel the
fibrillations, have shortness of breath, chest pain, fatigue and
feelings of anxiety, among other problems.
“For some patients, it’s a difficult way to live,” says
Phillip S. Cuculich, MD, assistant professor of medicine and
a cardiac electrophysiologist who treats patients with atrial
fibrillation at Barnes-Jewish Hospital.
Atrial fibrillation occurs when the upper chambers of the
heart, called atria, get irregular electrical signals that disrupt
the coordinated pumping of blood through the heart to the
outlook.wustl.edu

rest of the body. Instead of a normal beat, these signals cause
the heart to quiver, preventing adequate blood flow to the
ventricles, the heart’s main pumps.
Despite its prevalence, atrial fibrillation remains tricky
to treat. Medications that maintain a normal heart rhythm
often stop working after a period of time.
“I tried medication,” Gaal says. “They thought it was
working. But within a day or two after they released me from
the hospital, I felt the fibrillations starting up again.”
When medication fails, doctors typically recommend
catheter ablation, which involves threading long, thin
tubes through a vein in the groin into the heart. The tips of
these catheters can be heated, allowing doctors to perform
a series of ablations, or burns, on the heart’s inner surface.
The goal of ablation therapy is to create scar tissue that
isolates the irregular electrical signals and blocks them from
Outlook 9

Steve Gaal tries out his
newly revised heart.

spreading over the heart and causing fibrillation. After a catheter ablation procedure,
about 70 percent of patients remain free of
symptoms after one year.
Although success rates for catheter ablation
are higher than medication, it doesn’t always work;
some patients may require a second or third procedure
to achieve a successful result. And it does not work well for
patients with an enlarged left atrium, like Gaal.
For these hard-to-treat patients, doctors may recommend
the Cox-Maze surgical procedure, developed in 1987 by
James L. Cox, MD, at Washington University.
With a high success rate, the Cox-Maze procedure is
considered the gold standard of atrial fibrillation treatment.
The original Cox-Maze procedure has been refined by Ralph
J. Damiano Jr., MD, the John M. Shoenberg Professor of
Surgery, and is effective in 90 percent of patients. Damiano
has made the procedure easier to perform and more widely
available. But many patients consider it too invasive.
“If you have other open-heart cardiac surgery that you
need, like bypass surgery or valve surgery, and you have
atrial fibrillation, the Cox-Maze procedure is an excellent
choice to do at the same time,” Cuculich says. “But most
of my patients just have atrial fibrillation.”
After medication failed and since he had no other heart
problems, Gaal’s doctors determined he would be a good
candidate for the hybrid procedure. Available at only a handful of U.S. medical centers, the hybrid approach attempts to
recreate the success rates of the Cox-Maze procedure with
the minimally invasive nature and shorter recovery times
associated with catheter ablation.
Because catheters enter through a vein, electrophysiologists only have access to the inside of the heart. A surgeon,
in contrast, can provide access to the outside.
“By applying the energy to make scars from both the
inside and outside of the heart, we’re better able to achieve

a full-thickness ablation,” says Hersh S.
Maniar, MD, assistant professor of surgery,
who performs the new hybrid procedure and
the Cox-Maze. “A complete scar that crosses
through the full thickness of the heart wall will
more permanently block atrial fibrillation signals.”
To avoid open surgery, the hybrid procedure is
performed through three small incisions under both of the
patient’s armpits. The surgeons view their work by inserting
a small camera into one of the incisions.
After the surgeon has performed the ablations on the outside of the heart, the electrophysiologist uses the catheters
inside the heart to attempt to induce a fibrillation, testing the
integrity of the ablation lines. If the atrial fibrillation persists,
the electrophysiologist can touch up the ablation lines inside
the heart until fibrillation can no longer be induced. Finally,
the surgeon closes off the left atrial appendage, the area of the
heart where most stroke-causing blood clots originate.
A clinical trial is planned to compare the new hybrid
procedure to catheter ablation in patients whose atrial fibrillation is persistent, meaning it does not start and stop on
its own, and whose left atrium is enlarged. This group of
patients has not done well historically with catheter ablation.
But outside the clinical trial, the procedure is now available to any patient with atrial fibrillation after consultation
with his or her doctor.
“Right now we’re doing this for people who have persistent atrial fibrillation and for people who have had a failed
catheter ablation procedure,” Cuculich says. “I think this is
an important step forward in improving patient quality of
life in a less invasive way than traditional surgery.”
Gaal is pleased with the results.
“I’ve had no recurrences of the fibrillations since the
procedure,” he says. “I feel good and I know in the next
few months I’m going to be that much better. I’m looking
forward to it.”

TIM PARKER

Phillip S. Cuculich, MD, left, and
Hersh S. Maniar, MD, display
the tools that make a “hybrid”
procedure for atrial fibrillation
so successful.

22 Washington University School of Medicine
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Atrial Fibrillation

Ins & Outs
Washington University physicians at Barnes-Jewish
Hospital pioneered the surgical treatment of atrial
fibrillation. The original procedure involved opening
the chest, stopping the heart and applying a “maze”
of incisions. Although this proved highly effective,
researchers continued to seek less disruptive
approaches. Incisions can be replaced by controlled
scars, called ablations, created with electrical currents
applied in or on the beating heart. However, the
limited depth of such scarring permits tissue to regrow,
and fibrillation can recur. Now, a team of specialists has
joined forces to perform inner and outer ablations
during one minimally invasive surgery, offering
effective treatment and quicker recovery.
SURGEON

Operates an electrical
clamp on the heart

3

Outside the heart
A surgeon performs a
series of ablations on the
heart’s outer surface
(step 1, right). These burns
surround the pulmonary
veins, where the erratic
signals that cause atrial
fibrillation often originate.

Inside the heart

InformatIon graphIc by ErIc young • aDaptED from SErVIEr mEDIcaL art

ELECTROP HYS I O LO G I S T
Inserts electrical
catheters through
veins in the groin;
operates the
catheters inside
the heart

An electrophysiologist
uses catheters to perform
ablations on the inner
surface (2) to further
contain the signals.
ANATOMICAL VIEW

Left atrium
connects to
pulmonary
veins

outlook.wustl.edu

1
2

Final steps
The electrophysiologist
tests the heart to see if
fibrillation is impeded;
more work may be needed
(see below). Lastly, the
surgeon removes the left
atrial appendage (3), a
point of origin for blood
clots that can cause strokes.
ELECTROPHYSIOLOGY

Red shows that
fibrillation is fully
blocked; the gap
above means more
ablation is needed

Outlook 23

After
the MD

Once that piece of paper goes on the wall,
residents and fellows go to work in varied
programs that fire passions for medicine
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That effort is headed by Rebecca P. McAlister,
MD, professor of obstetrics and gynecology and
associate dean for graduate medical education, and
Tia O. Drake, director, graduate medical education.
“The job of the ACGME and our office is to
ensure that our programs meet established
standards,” says McAlister. “We ensure that we
maintain a quality educational environment for
all upper-level trainees in any of the residency
and clinical fellowship training programs at the
university or our affiliated hospitals.”
The GME office heads the Washington University
Barnes-Jewish Hospital St. Louis Children's Hospital
Educational Consortium. Postgraduate trainees can
be employed at any of the three institutions, but the
oversight for the educational environment resides
with the GME office, while the hospitals focus on
patient care and the physical environment.
“Our primary goal is to ensure that the people
we turn out at the end of their training are competent in an array of areas,” says Drake. "These
include their medical knowledge, their professionalism, and their ability to communicate."

Rebecca P. McAlister, MD, far left, and
Tia O. Drake, far right, meet regularly
with residents, fellows and their
program directors to discuss issues
related to postgraduate clinical training.

Spring 2010

SARAH DOLAN, PAC AND OLIVIA CUKIERMAN, RN

M

edical school may teach
the basics, but it is post–
graduate education that
truly prepares young physicians to
independently practice medicine.
The Accreditation Council for
Graduate Medical Education (ACGME)
is the main accrediting body for U.S.
residency and fellowship programs.
At Washington University School of
Medicine, the Office of the Associate
Dean for Graduate Medical Education
(GME) maintains oversight of accreditation for all postgraduate clinical training.

B Y H O L LY E D M I S T O N

Enjae Jung, MD,
in the OR.

A bond of trust

ROBERT BOSTON

F

ourth-year surgery resident Enjae Jung, MD,
is actually in her sixth year of post-MD
training. After earning her medical degree
at Washington University School of Medicine
in 2006, she completed two years of residency,
followed by two years conducting basic research.
According to Mary E. Klingensmith, MD, the
Mary Culver Distinguished Professor of Surgery
and director for the general surgical residency
program, it is not uncommon among surgery
residency programs for trainees to spend two
years conducting dedicated postdoctoral research.
This training builds a foundation for future
academic research and funding; it also gives
residents an edge when applying for competitive
fellowship positions.
Jung’s passion for surgery was ignited when
she shadowed a surgeon as an undergraduate. She
applied to medical school intent on specializing in
surgery and has never wavered from that goal.
“I love the bond I share with my patients,” says
Jung. “There’s a lot of trust in allowing someone
to operate on you, and there’s a lot of emotional
investment when you’ve operated on someone.”
She credits the people who run, teach and
participate in the surgery residency program at
Washington University with making her experience so successful, and she notes that the GME
office also plays an important role.
outlook.wustl.edu

“The Department of Surgery leadership has put
measures into place that maximize our learning
while remaining compliant with ACGME restrictions, such as restriction of duty hours,” says Jung.
Compliance with duty hours and maintenance
of a quality educational environment for trainees
is a primary focus for the GME office. According
to Klingensmith, McAlister and Drake are readily
available for advice and insight when daily challenges in running a residency program arise.
Jung plans to take
advantage of an early
specialization program,
an opportunity offered
for physicians interested
in doing a fellowship in
vascular surgery. As she
completes her fifth year of
general surgery, she will
begin a two-year fellowship — Enjae Jung, MD
in vascular surgery.
Other aspects of the program also support the
transition from training to beginning a career.
“The faculty are national leaders, yet they are
approachable and interested in my education and
training,” says Jung. “I also have great colleagues;
my fellow residents are supportive, and we
definitely look out for each other.”

“The faculty are
approachable and
interested in my
education and
training.”
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Amit Patel, MD, left, and
Melvin S. Blanchard, MD,
examine patient Janet Garner.

Combining interests

A

mit Patel, MD, a second-year resident in
internal medicine and a 2010 graduate of the
School of Medicine, has a passion for research.
While patient care remains his focus, he currently is participating in CSTAR (Clinical Science
Training and Research), a residency training pathway that allows for three months of uninterrupted,
dedicated clinical research time.
“When you’re on clinical
rotations, our demanding hours
can make it difficult to partake
in research,” says Patel. “CSTAR
offers residents interested in
clinical research the opportunity
to learn how to prepare proposals
and conduct research that will
assist them in becoming successful clinician-investigators.”
Like his research mentor,
C.
Prakash
Gyawali, MD,
— Amit Patel, MD
professor of medicine, Patel
plans to specialize in gastroenterology. The field
includes an interesting array of procedures and
emerging technologies, but will still allow Patel
to build long-term relationships with his patients.
Patel also serves on the Washington University
Institutional Review Board and is co-authoring
several chapters in the Washington Manual
Subspecialty Consult Series, and serves as a senior
staff writer at iMedicalApps.com.

”The GME staff does a
terrific job. They stand
ready to ensure that
our education is both
expansive and fair.”
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“We have a number of special programs,
including career and research mentorship, training in how to conduct clinical research, training
in quality improvement, and education in global
health,” says Melvin S. Blanchard, MD, FACP,
associate professor of medicine, chief of the
Division of Medical Education, and director of
the Internal Medicine Residency Program.
Programs like these are what make residency
opportunities at Washington University School of
Medicine unique. The educational oversight of the
GME office ensures that every clinical program
offered meets ACGME guidelines.
That’s a safeguard Patel appreciates.
“The GME staff does a terrific job,” he says.
“They stand ready to ensure that our education is
both expansive and fair.”
Blanchard concurs, saying: “Dr. McAlister and
Tia Drake are very responsive, efficient and enthusiastic. They are very supportive of our educational
programs and curriculum, and their oversight
helps us facilitate the sharing of ideas across the
82 training programs at Washington University.”
Even with protections in place, residency training remains a challenging and difficult endeavor.
“You have to love what you do,” says Patel. “No
doubt residency can be exhausting at times, but if
you love taking care of patients and making them
feel better, you embrace its challenge and finish
each day with a sense of fulfillment.”
Winter
Spring 2010
2011
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iguring out the etiology of a patient’s presenting symptoms is what drew Sara W. Dyrstad,
MD, to radiology, a specialty that requires
careful study of anatomy and pathology using an
array of imaging techniques and procedures.
Now in her fourth and final year of residency,
Dyrstad plans to continue her training as a breast
imaging fellow at the Center for Advanced Medicine
at Washington University Medical Center.
“Radiology is a fascinating, challenging field
that allows me to have focused patient interaction
and to communicate with clinicians from a variety
of specialties,” says Dyrstad, who earned her medical degree in 2007 at Southern Illinois University
in Springfield, Ill. “No day is ever the same.”
Throughout residency training, Dyrstad has
channeled her passion for problem-solving beyond
medical issues to those that arise outside the
imaging suite.
Representing the Missouri State Medical
Association as a section delegate for the Resident
and Fellow Section of the American Medical
Association (AMA), she has been active in the
national discourse about postgraduate education.
“Sara’s involvement with the AMA underscores
her commitment to radiology and the future of
medicine,” says interventional radiologist Jennifer
E. Gould, MD, assistant professor of radiology and
diagnostic radiology residency program director.
“That commitment, coupled with her level-headed
approach to issues, made her an easy choice as a
resident representative to the GME
Consortium committee.”

outlook.wustl.edu
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For the past year and a half, Dyrstad and
three other postgraduate trainees have served
on the committee, composed of GME and hospital
administrators, residency and fellowship program
directors, and residents and fellows. Most recently,
they have focused on providing a peer forum for
postgraduates to help
address any possible
concerns that may arise
during their training.
“It’s great to be a contributing member to the
GMEC,” says Dyrstad.
“Not only do we get to
— Sara W. Dyrstad, MD
voice our concerns, we
also gain insight into global
issues that affect residency training, such as duty
hour restrictions, and possible program changes.”
“Sara has been a delight to have as a resident,”
says Gould. “She has matured over her four years
of training to become a leader. Her ‘can-do’ attitude and willingness to jump in and work hard
make her a pleasure to have on service.”

“As contributing GMEC
members, we get to
voice our concerns.”

Different every day

Sara W. Dyrstad, MD, left, and
Jennifer E. Gould, MD, study
an image in the interventional
radiology suite.

Outlook 15

T H E P A S T 3 0 Y E A R S has seen a revolution in the
treatment of injuries to peripheral nerves. Arms and legs,
hands and feet rely on peripheral nerves to function and feel,
and a few surgical specialists across the country have devoted
their careers to fixing these delicate white fibers when they
are damaged or broken. And behind the scenes, informing all
of this surgical work, is the laboratory.
“Every question that comes up in the clinic,
we have looked at in the laboratory,” says Susan
E. Mackinnon, MD, the Shoenberg Professor and
chief of the Division of Plastic and Reconstructive
Surgery. “We bring the answers we discover in the
lab back to the clinic and the operating room.”
Over three decades, this flow of information between
laboratory, clinic and OR has led to huge shifts in the
understanding of nerve injury and regeneration. Limbs that
might once have been amputated can be saved: A patient’s
own healthy nerves can be rerouted into a damaged limb,
and nerves from a cadaver can be transplanted while
minimizing risk of rejection.
A major figure in this work is Daniel A. Hunter, senior
scientist in Mackinnon’s lab and an expert in the microscopic
analysis of nerves. Mackinnon calls Hunter’s work an integral
part of her surgical practice.
“Dan has devoted his life to quantifying nerve regeneration
and developed his own unique techniques to measure what
we see under the microscope,” Mackinnon says. “He can make
the visual images of nerves — and they’re beautiful images
— into actual numerical results. So you can compare different
strategies for treating nerve injury in a very scientific way.”

The
Cutting
Edge
Behind-the-scenes
lab work points
toward beneficial
treatments for
otherwise devastating
nerve injuries.
BY JULIA EVANGELOU
STRAIT

C O N T I N U E D O N PA G E 2 0
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Imaging techniques developed by Dan Hunter and colleagues
in the peripheral nerve lab set a standard for quantitative
analysis of regeneration. Hunter modified computer software
to augment the painstaking application of his lifetime of
research experience. Above and below: Examples show how
raw images are progressively refined to yield valuable data.
ROBERT BOSTON

Exacting peripheral nerve studies
inform breakthrough
surgical procedures
Neural pathways
The peripheral nervous system
sends neural impulses to and from
the brain, directing the body as
it interacts with its environment.
Injuries can impair or sever these
vital links. But research shows that
this system can be re-engineered
to restore essential functions.

Whole
nerves
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If a human hair
were this size. . .

A close
shave

Slices float
onto pool
of water

a slice of nerve cut with
an ultramicrotome
would be about this size
(red line).

Neural
fiber

Seek
and find
Assessing nerve regeneration
experiments requires human
and computer prowess in a
painstaking, multistage effort
that results in quantified data.

Nerve
encased
in resin

Processing to clarify the image

1
Initially, information clutter

2

Viable nerve fibers mapped

Applying false color to label
each fiber and its myelin sheath

Custom-made
triangular
glass knife, with
water reservoir
attached

Nerve sample
prepared for
microsopy

3

Separating the components
for computer analysis

Mathematical analyses of
image data define the most
promising treatments.

Applied in the OR
Ulnar nerve damaged
in upper arm

Nerve
surgically rerouted

The surgeon plugs a non-critical nerve into an
injured nerve; at the microscopic level, new
connectivity begins forming (elongated fibers,
left). With therapy, the patient can regain
elaborate neuromuscular functions
such as crossing her fingers.

The Cutting Edge

LINDA SCHALLER

On Hunter’s first day working for Alan Hudson, MB ChB,
who later became neurosurgeon-in-chief at St. Michael’s
Hospital in Toronto, the windowless basement lab had a
rotary telephone, a typewriter, an old surgical microscope,
and an ultramicrotome, a device used to slice impossibly
thin sections of biological samples to look at under microscopes. It was 1973.
“Dr. Hudson handed me a box of rat nerves,” Hunter
recalls. “I asked what I should do with it, and he said, ‘You
figure it out; I’m going on vacation.’ And he left. That was like
baptism by fire. I think it was a test to see what I could do.”
In 1978, as a plastic surgery resident at the University
of Toronto with an interest in nerve injury, Mackinnon
sought out the Hudson lab. There, she and Hunter used animal models to do the first studies of immune response and
rejection in transplanted nerve, paving the way for the first
human nerve transplant, performed by Mackinnon in 1988.
Today at Washington
University, 38 years after his
first days in the lab, Hunter
still works in a windowless room. Rotary phones
and typewriters have made
way for computers and cell
phones. But the ultramicrotome, transplanted from
Toronto, remains.
Surgeries use nerve regeneration
Since this particular
techniques first verified by imaging
ultramicrotome is no longer
studies in the peripheral nerve lab.
manufactured, Hunter does
any required maintenance
himself. Perhaps reminiscent of the transplanted nerves he
examines, he harvests replacement parts from his stash of
secondhand ultramicrotomes of the same make and model.
Though modern ultramicrotomes use diamond knives,
Hunter prefers the instruments and methods he perfected
early in his career. “I’m old school,” Hunter says with a laugh.
“If I had to switch instruments, I think I would just leave.”
The glass knives he makes himself are sharper than
diamond, but more fragile. After only a handful of cuts,
the edge dulls and the knife must be replaced. Neat rows of
triangular glass knives sit on Hunter’s bench top, waiting to
be mounted in the ultramicrotome to slice cross sections of
nerves embedded in a hard epoxy resin.
A microtome is termed “ultra” when it cuts samples even
thinner than the already thin sections cut by regular microtomes. With his vintage ultramicrotome, Hunter can cut
sections as thin as 60 nanometers. That’s 1,000 times thinner
than a human hair. Indeed, the sections are so thin they cannot be handled directly, but are collected on the surface of a
tiny pool of water flush with the glass cutting edge. Floating
on the water’s surface, the sections appear in vibrant colors
— tiny postage stamps of shimmering blues, greens, or
20 Washington University School of Medicine

purples depending on their thickness. The same complex
optical physics is at work in the rainbow of colors seen in
thin films of oil floating on street puddles.
Hunter scoops these samples up with a platinum wire
loop and mounts them on glass slides for light microscopy or
on metal grids for the extreme close-up view provided by an
electron microscope.
In the images of nerve cross sections, the average person
sees wiggly lines, circles with thick borders, circles with thin
borders, dots and splotches of all shapes and sizes. But to
Hunter, each nerve section tells a story.
“This is a crush injury,” he says, pointing to the small
circles in one of the images.
When a nerve is crushed, the layer of insulation surrounding the nerve fibers, called myelin, gets thinner. But
the axon, the “wire” that transmits electrical signals, stays
the same. As the myelin sheath thins, the axon’s electrical
signals slow down.
“This axon here is dying,” he explains. “It’s being torn
away from the myelin. Some scientists may not count these
accurately because they can’t distinguish between viable and
nonviable axons.”
Originally, Hunter counted axons and examined nerve
sections entirely by hand. Seeking to speed up his process, he
found help from an unlikely source: He co-opted an imaging
system intended for examining metals — iron, steel, alloys
and ores — and wrote his own programs to make the system
analyze nerve cross sections instead.
“I don’t even know how he came up with that,” says
Mackinnon. “But for every new operation that I develop,
Dan looks at the nerve regeneration in animal models first
and tells me whether the new technique worked.”
Hunter’s methods have proven so comprehensive that
researchers at other universities have purchased the metallurgy software platform to use with his custom peripheral
nerve programs. Groups at the University of Pittsburgh,
Massachusetts General Hospital, the University of Texas
Southwestern Medical Center at Dallas, and Chang Gung
Memorial Hospital in Taiwan are now using Hunter’s system
in their own nerve investigations.
“Dan has been doing this type of analysis on nerves his
entire career,” Mackinnon says. “He has really focused on
that with tremendous intellect and passion and become
extraordinarily expert in it.”
Hunter calls these meticulous methods the gold standard
in quantifying the state of a nerve, whether healthy, injured
or regenerating.
“It gives us far more information than any other tool to
assess nerve regeneration,” he says. “Other groups might
choose to only count axons. And I’m not saying that’s right
or wrong. We are just extremely comprehensive when we
look at nerve injury and regeneration. That’s one aspect of
our lab that sets us apart.”
Winter 2011

The remarkable life of a celebrated
clinician/mentor /scientist /citizen

In this portrait, Bernard
Becker, MD, holds the first
comprehensive text on eye
diseases and treatments, a
rare 16th-century book from
the extensive collection of
ophthalmology texts that
he donated to the School
of Medicine's library, later
named in his honor.

Becker’s

(re)collection(s)
IN ONE WAY OR ANOTHER, nearly everyone at the
School of Medicine has heard of Bernard Becker, MD.
Many use the beautiful Bernard Becker Medical Library or
consult rare eye books there from the well-known Becker
collection. In the Department of Ophthalmology, which
Becker chaired for more than 35 years, faculty members
know well his landmark research on glaucoma. One member,
David C. Beebe, PhD, is the Janet and Bernard Becker
Professor of Ophthalmology and Visual Sciences.
But Becker is much more than a portrait in the library.
B Y C A N DAC E O ’CO N N O R
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Accepted leadership
of ophthalmology
department in 1953 at
age 33, becoming the
university’s youngest
chairman; served for
35 years

Looking back on the storied career of a
clinical scientist, a “jack-of-all-trades”

Military service in World War II

His 500 publications
contributed to the
understanding of
glaucoma

Authored influential
ophthalmology
textbook

BERNARD BECKER, MD

Taught and inspired
legions of students
ADAPTED FROM A PRESENTATION BY GEORGE M. BOHIGIAN, MD

At 91, Becker is still a vital force in the lives of his former
colleagues and residents, some 18 of whom went on to head
ophthalmology departments of their own. Though wheelchair-bound from hip and vertebrae fractures, he is still
highly alert and active on the computer, reading journals
and sending articles to colleagues around the world.
“It’s a compulsion of mine. When I read an article, the
first thing that occurs to me is: ‘My gosh, this is something
so-and-so needs to know about,’” says Becker.
According to Michael A. Kass, MD, the Bernard
Becker Professor and current head of the Department of
Ophthalmology and Visual Sciences, Becker’s greatest legacy
is the people he trained and continues to influence. “He
inspired us to pursue excellence, question dogma, and seek
answers to important basic and clinical questions,” says Kass.
And Becker is still winning awards, though he modestly
downplays them. The American Academy of Ophthalmology
honored him with its prestigious Laureate Recognition
Award in 2009. From the Association for Research in Vision
and Ophthalmology (ARVO), an organization he was instrumental in founding, Becker has received the Proctor Medal,
the Friedenwald Award and the Mildred Weisenfeld Award.
But another legacy, and one that Becker values equally,
is the work that he and his wife, Janet, have done to further
social justice. He still uses his contacts to raise money for
causes such as combatting homelessness, feeding the hungry,
housing ex-offenders and offering scholarships to students.
“My wife and I were brought up Jewish, and we both faced
discrimination,” he says of his commitment. “I was also
brought up to like people no matter what their religion.”
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Childhood and Education

Growing up in Brooklyn, Becker was early, and excellent,
at everything he attempted. As soon as he started school,
he was promoted to third grade — and from then on was
younger than everyone in his classes. After high school, he
won a scholarship to Princeton University, where he was one
of six Jewish students in a class of 400. He tutored wealthy
young men to supplement his budget.
At Princeton, Becker became a chemistry major and
worked with the head of the department, H.S. Taylor, PhD,
in researching the structure of molecules, especially proteins and polypeptides. Taylor wanted him to continue on
for a PhD in chemistry, but Becker felt that medical training would allow him to apply his research. So he went to
Harvard Medical School on a scholarship and worked in the
laboratory of A. Baird Hastings, PhD, head of biochemistry.
With World War II under way, Becker finished medical
school and his internship on a truncated schedule and
served in the military.
Afterward, he might have stayed in biochemistry if not
for a fortuitous meeting with Jonas S. Friedenwald, MD,
a renowned histochemist at Johns Hopkins University.
Friedenwald had a dazzling intellect, and when he invited
Becker to Hopkins for his residency, Becker eagerly
agreed. But he didn’t fully realize that ophthalmology was
Friedenwald’s primary interest — and thus Becker began his
migration toward eye research.
“That was an exciting time,” says Becker. “Friedenwald
was a brilliant man, who even knew all about legal things —
all about everything. When they needed advice on the
Winter 2011

Founded Association
of University Professors
of Ophthalmology

Built Association for
Research in Vision and
Ophthalmology (ARVO)

Helped establish
National Eye Institute

Directed
American Board of
Ophthalmology

First editor of
Investigative
Ophthalmology and
Visual Science

With his wife, Janet,
championed the poor,
the homeless, the
disenfranchised

Attending Grand Rounds

Remade School of
Medicine library,
donating his
600-volume collection
of rare eye texts

U.S. Supreme Court, they called on him; in fact, Justice Felix
Frankfurter used to come to the lab to visit with Friedenwald
and talk about issues coming up before the Court.”
During the five years that he spent at Hopkins, Becker
developed methods for diagnosing glaucoma and measuring
aqueous humor, directed the residency program, did nonstop research and served as chief resident. At age 30, he
celebrated one of his happiest accomplishments: marrying
his wife, Janet, a Philadelphia-born Sarah Lawrence graduate
deeply committed to civil rights.

The Washington University Years

Before his marriage, Becker roomed with fellow ophthalmology resident Lawrence Post Jr., MD, son of the parttime ophthalmology chairman at Washington University,
Lawrence Post Sr., MD. Word got back to the School of
Medicine about Becker, and at the end of his third residency
year, Dean Robert A. Moore, MD, recruited him to head the
Department of Ophthalmology, but Becker refused. When
Moore tried again two years later, Becker accepted. At age 33,
he was the university’s youngest department chairman.
Arriving in St. Louis in 1953, Becker faced some
immediate challenges, among them building up the residency program, creating a strong research focus, hiring new
faculty and forging a solid relationship with community
physicians. At the same time, he took on important national
roles: founding ARVO, serving as first editor-in-chief of
Investigative Ophthalmology & Visual Science, and traveling
outlook.wustl.edu

The Becker Collection of books,
manuscripts and graphics, housed
in the Becker Library's Archives and
Rare Books, includes many rare items
chronicling the parallel evolution of
ophthalmology and scientific optics.

the country to convince medical schools they should establish full-time ophthalmology departments with NIH funds.
Horrified by the segregation that he found in McMillan
Hospital, he adamantly insisted that it be integrated, and he
also appointed African Americans to the staff, among them
Howard P. Venable, MD. At the same time, Janet Becker was
working in the community, forming organizations such as
Beyond Housing.
“In those days, every floor in the hospital had cigarette
machines — and this was the institution that had established
the link between smoking and lung cancer!” says Becker.
“I was a rebel, and I insisted they take the machines off the
floors. The only one who would support me was Carl Moyer,
head of surgery, because there was so much money to be
made from them.”
He also managed to continue his own research, amassing
some 500 publications and writing a well-known textbook,
Diagnosis and Therapy of the Glaucomas, still in use today.
Altogether he served for 35 years as department chair, stepping down in 1988. Next he took on the project of remaking
the inadequate library, later named for him in recognition of
his work. For years he had been buying precious eye texts, and
he donated the entire 600-volume collection to the archives.
Among his and Janet’s five living children, one is also
an ophthalmologist — William L. Becker, MD 87 — while
the other four sons include a teacher, artist, musician and
craftsman. The couple also has 10 grandchildren. But Becker
has other “children,” too, he says. “Teaching people to do
research and take care of patients spreads your ability to do
good. And that carries over.”
Outlook 23

viewpoint

Medicine

GONE WRONG
Exhibit shows how a cloak of spurious
health claims once hid a deadly agenda

I

MAGINE BEING A CHILD IN 1930s GERMANY,
called into a room where a man in a white coat
holds up charts next to your face to look at your
eye color and uses tools to measure the bridge of
your nose, width of your forehead and circumference of your head.
Hundreds of thousands of children and adults
were measured this way by physicians, who also
recorded family genealogies to trace
hereditary traits. The practice was
part of a broad effort using German
physicians and others to racially
“cleanse” European society of people
seen as biologically inferior and
those perceived as racial enemies of
the German people.
This practice of the “science” of
eugenics, or racial hygiene, as it
was known in Germany, is featured
in “Deadly Medicine: Creating the
Sign of the times: A British poster from
Master Race,” a traveling exhibition
the early 1930s promotes the surgical
sterilization of genetic “inferiors.”
from the United States Holocaust
Memorial Museum recently on display at the School
of Medicine’s Bernard Becker Medical Library.
The exhibit highlights the role of science and
medicine in the Holocaust.
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“Our starting point is not the individual,
and we do not subscribe to the view
that one should feed the hungry, give
drink to the thirsty, or clothe the naked.
. . . Our objectives are entirely different:
We must have a healthy people in order
to prevail in the world.”
— Joseph Goebbels,
German Minister of Propaganda, 1938

Winter
Fall 2006
2011
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BY BETH MILLER

In the 1930s, the National Socialist (Nazi) party
enacted a law preventing “genetically diseased offspring” by a mass sterilization program. This emulated sterilization laws enacted decades earlier in
the United States and the Scandinavian countries.
More than 400,000 German citizens were sterilized
over the next 13 years for hereditary conditions
including schizophrenia, manic-depressive disorder, genetic epilepsy, genetic blindness or deafness,
and severe physical deformity, among others.
Midwives and physicians were enlisted to register all children born with severe birth defects and,
during World War II,
the program was
expanded to include
children and adults
deemed “incurable.”
They were sent to
specialized hospital
centers, where they
were then gassed or
Dr. Friedrich Mennecke and his
starved to death. The
wife, Eva, served Operation 14f13,
Nazis justified these
which expanded gassings to
as “mercy deaths,”
concentration camp inmates too
using asylum direcsick to work and, more broadly,
tors, physicians and
to Jewish prisoners.
nurses to end “lives
unworthy of life” for the good of the Fatherland.
In 1942, the “euthanasia” program and its medical personnel were moved to German-occupied
Poland. There, in camps specially constructed as
killing centers, gas chambers were used to murder
millions. It was to these death camps that 6 million
Jews and hundreds of thousands of Romany were
transported from throughout Europe and killed in
a policy of total extermination (“the final solution”).
Nazi killing centers where millions perished: Jews, Gypsies,
non-Jewish Poles, and Soviet prisoners of war

Jews as “microbes” and
Bolsheviks as “germs,”
from Nazi journal
Der Stürmer (The
Attacker), 1943

“‘Deadly Medicine’ helps us understand how
our contemporary world came to be and the
human stakes involved in trying to improve
the human race,” says Stephen S. Lefrak, MD,
professor of medicine and assistant dean of the
Humanities Program in Medicine. “If history
teaches us anything, it is that what has happened, can in fact happen. It certainly behooves
an engaged citizen to comprehend that National
Socialist Germany was a biological state that
sought humankind’s perfection through racial
and biological selection. Therefore, for medicine in
the age of genomics, in vitro fertilization and the
search for wonder cures, the exhibit is a striking
billboard warning us to be wary of the promise of
biological utopian fantasies.”
Robert W. Sussman, PhD, professor of anthropology in Arts & Sciences, says the exhibit presents many historical events and ideas that aren’t
commonly known.
“In many cases,
people don’t realize
how medicine and
science can be used
in such a very bad
way,” Sussman says.
“People have forgotten how horrible
Hartheim “euthanasia” center
those things that
staff enjoying leisure time,
occurred during
circa 1940–42
World War II were.
The ‘Deadly Medicine’ exhibit shows very well
the connection between medical scientists and
anthropologists and how the American eugenics
movement influenced the Nazis.”
Sussman says many of the ideas presented in
the exhibit about different races are still an undercurrent in the United States today.
“This exhibit really shows how people can
think so differently, how the behaviors we think
are atrocious can be really part of their culture.”

“Don’t Go Blindly Into
Marriage!” In 1926, officials
in Berlin opened the first
eugenics bureau that certified fitness for marriage.

Choosing a Mate

(excerpts)

Remember that you are a
German. Everything you are
is not of your own merit but
through your nation.
If you are hereditarily
healthy, you should not
remain unmarried.
As a German choose only
a spouse of the same or
Nordic blood. The mixing of
races that do not match each
other . . . frequently leads to
degeneration and downfall in
the life of people and nations.
Seek a companion in marriage and not a playmate.
The purpose of marriage is
having children and raising
descendants. Only among
mentally, physically and racially
homogenous people can this
ultimate goal be achieved.
“Ten Commandments for Choosing
a Mate,” created by the Reich
Committee for Public Health.
From the pamphlet May I Marry
My Cousin? [1935]

Based on an exhibit that opened at the U.S. Holocaust
Memorial Museum in Washington, D.C., in April 2004.
Visit ushmm.org/deadlymedicine
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exceptional faculty

BY DIANE DUKE WILLIAMS

Mission forward
Alumni endowed professorships support full range of faculty efforts

F

or clinician Alan C. Braverman, MD,
having an endowed professorship is a
tremendous honor.
“I am very grateful to the alumni for this professorship,” says Braverman, the Alumni Endowed
Professor of Cardiovascular Diseases. “Washington
University is an incredible research facility, and
we also want to be known for providing excellent
clinical care. When we give these professorships to
clinicians, it highlights the mission of the medical
school in research and clinical care.”

In addition to his clinical practice, which covers
all aspects of noninvasive cardiology, Braverman is
a nationally known authority on genetically triggered aortic diseases such as Marfan syndrome and
thoracic aortic aneurysms and dissections.
Braverman’s professorship helps him conduct
clinical research projects on aortic dissections and
aneurysms that would not have been possible otherwise. It also provides support for the Washington
University Marfan Syndrome and Genetically
Triggered Thoracic Aortic Aneurysm Clinic.

Alan C. Braverman, MD,
with cardiology patient
Thomas Stobbs.

ROBERT BOSTON

Through the work of faculty
such as Braverman and Jeanne
M. Nerbonne, PhD, Alumni
Endowed Professor of Molecular
Biology and Pharmacology, left,
new knowledge is created and
the next generation of physicians and scientists is trained.

Endowed professorships help to attract and retain exceptional faculty like Braverman, and these professorships are
among the highest honors that a university can bestow on
its researchers, clinicians and teachers.
In 1978, the Alumni Endowed Professorship program
was established with the goal of creating one professorship
in each department of the School of Medicine. The professorships are funded by unrestricted gifts of $1,000 and
greater from medical alumni and former house staff.
To date, the program has funded nine professorships.
The first Alumni Endowed Professorship at the School of
Medicine, established in 1982, was held by Philip Needleman,
PhD, in the Department of Pharmacology.
The first endowed professorships, supported by private
philanthropy, were established at the School of Medicine in
1910. To date, 159 professorships, including alumni endowed,
have been created. These professorships have helped propel
the medical school into the world-renowned institution it
has become.
With endowed professorships, the income from permanently invested funds provides salary, benefits and research
support. Endowed professorships guarantee a stream of
funding that helps to offset the vagaries of external research
funding, which often enables researchers to pursue projects
at the frontiers of current knowledge and understanding.
An endowed professorship continues as long as the
university endures, representing a commitment to support
and sustain the advancement of the medical school.

ROBERT BOSTON

It was an incredible honor to receive the Alumni Endowed

Professorship in Molecular Biology and Pharmacology in
2001, says Jeanne M. Nerbonne, PhD. She admits, however,
that at the time she had little idea of what that honor would
mean in practical terms.
outlook.wustl.edu

“Over the years, the impact of the salary support
provided by the professorship has moved my laboratory’s
research in new directions and has allowed us to pursue new
initiatives as opportunities presented themselves, rapidly
broadening the scope and impact of our work,” she says.
She adds that a clear case in point is the recent establishment of the Translational Cardiovascular Tissue Core at
Washington University, a multi-investigator, collaborative
effort that Nerbonne is leading with additional seed funding from the Institute for Clinical and Translation Sciences
(ICTS) and the Children’s Discovery Institute.
Such initiatives are what keep Washington University
School of Medicine at the forefront of medical science and
patient care. Alumni Endowed Professorship are just one
of many ways to show support for the school’s mission.

Alumni Endowed Professorships
Dora E. Angelaki, PhD
Anatomy and Neurobiology

Douglas E. Berg, PhD
Molecular Microbiology

Alan C. Braverman, MD
Cardiovascular Diseases

Elliot L. Elson, PhD
Biochemistry and Molecular
Biophysics

Robert P. Mecham, PhD
Cell Biology and Physiology

Jeanne M. Nerbonne, PhD
Molecular Biology and
Pharmacology

David M. Ornitz, MD, PhD
Molecular Biology and
Pharmacology

Robert D. Schreiber, PhD
Pathology and Immunology
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BY MICHELE HOEFT

History of medicine useful in guiding the future

G

George M.
Bohigian, MD

eorge M. Bohigian, MD,
professor of clinical
ophthalmology and visual
sciences, knows the importance of
connecting with others.
He began his career as a high
school science teacher after earning
an undergraduate degree (LA 61,
zoology) and a teaching certificate
from Washington University. He
soon realized he wanted to make
an even bigger difference, which
brought him to medical school and
then Washington University School
of Medicine for his residency.
During his residency, Bohigian
was inspired by the chairman of the
Department of Ophthalmology and
Visual Sciences, Bernard Becker, MD.

“Dr. Becker is one of the most
brilliant people I have ever met,”
says Bohigian. “He taught me how
to think critically and encouraged
the residents to do good research.”
Becker also had an impact
on Bohigian’s future interests. It
was Becker who first urged him
to present a paper at the Cogan
Ophthalmic History Society; today,
Bohigian serves as its president.
The study of history not only
gives him an appreciation of the
past and present, but also serves
as a guide to the future, says
Bohigian. He finds this knowledge
helpful when treating his patients.
Bohigian describes one of his
life’s purposes — teaching — as

“being able to share your light and
knowledge with those around you.”
Bohigian’s connection to the
university continues to shine.
He and his wife, Chris, have
recently established the Bohigian
Lectureship in Ophthalmic History
and Visual Sciences.
They know that philanthropy
strengthens both the university
and the St. Louis community.
“We are pleased to support
Washington University School of
Medicine and to emphasize the
importance of history,” says George
Bohigian. “The newly formed
Center for History of Medicine at
the medical center should be a
valuable addition to this endeavor.”

Support to train audiologists and therapists

G

James W.
Seeser, PhD, and
his wife, Judy

rowing up with deaf parents put James W. Seeser,
PhD, in an unusual role.
As the oldest child in his family,
Seeser served as an interpreter for
his parents, landing him squarely
in the adult world. He remembers
negotiating a car purchase with his
father when he was just 6 years old.
Still, he never truly felt he could
bridge the gap. “Being deaf in a
hearing world, my parents lived
in a parallel universe,” says Seeser.
“Being unable to fully communicate is a huge barrier.”
Those early lessons taught him
self-reliance and left him determined to figure things out for
himself, a trait he carried into his
chosen field of science.
From his parents, Seeser gained
strong ethics and morals. He also
learned about giving back and has
used that knowledge to become
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personally involved in helping
other families that are affected by
hearing issues.
Realizing that educating
future audiologists and therapists
is crucial to helping hearingimpaired children, Seeser donates
annually to support scholarships established in Washington
University School of Medicine’s
Program in Audiology and
Communication Sciences (PACS).
“Jim Seeser has been an important friend and supporter for the
PACS programs for a number of
years,” says William W. Clark, PhD,
professor of otolaryngology and
director of PACS. “His passion and
motivation stem from his personal
experience as the child of deaf
parents; his experience as a fellow
academician and research scientist
make him a valuable colleague and
consultant to our programs.”

Seeser credits Jerome R. “Jerry”
Cox Jr., ScD, senior professor in
computer science, with his involvement in the PACS program at
Washington University. Through
Cox and Clark, he has learned the
importance of data gathering and
sharing information with parents
as they make decisions for their
hearing-impaired children.
Early diagnosis and the use
of hearing technologies such as
cochlear implants and digital hearing aids provide the opportunity
for hearing-impaired children to
maximize their ability to function in
the hearing world.
“Jim Seeser’s vision, business
experience and entrepreneurship
are valuable resources, and his
financial support helps us achieve
the goals we share,” says Clark. “We
want to attract and train the most
highly qualified leaders in the field.”

Winter 2011

The 2011 2nd Century Awards were presented at a dinner
held at the Ritz-Carlton Hotel in Clayton on September 16.
The awards recognize those whose long-term commitment
and participation have truly made a difference and whose
ongoing support allows the School of Medicine to move
forward in its second century with strength and confidence.
Robert G. Clark is the chairman and CEO of Clayco, a
firm specializing in real estate development, engineering,
architecture and construction in industrial, corporate, institutional and residential markets. Clark and his late wife,
Ellen, dedicated their time and resources to a broad range
of critical issues. The Clark family recently made a gift to
Washington University School of Medicine to build and
dedicate the Ellen S. Clark Hope Plaza to the school.
Timothy J. Ley, MD, the Lewis T. and Rosalind B. Apple
Professor of Medicine, is a hematologist, oncologist and
cancer biologist. He is an internationally known expert
in the pathogenesis of acute myeloid leukemia (AML) and
other blood-related disorders. Ley, with other researchers,

MARK BEAVEN

2nd Century awardees
honored at annual banquet

2011 2nd Century Award recipients, from left:
Robert G. Clark, Morton E. Smith, MD, and Timothy J. Ley, MD

was the first to use the reference sequence of the human
genome to systematically identify the mutations responsible
for the initiation and progression of cancer, focusing primarily on AML. In addition, his laboratory was the first to
develop an accurate mouse model of AML and the first to
sequence a mouse cancer genome.
Morton E. Smith, MD, professor emeritus of ophthalmology and visual sciences and associate dean emeritus for postgraduate education, began teaching students at the School of
Medicine in 1967. Now in his fifth decade with the university,
he continues as a lecturer in ophthalmology and pathology.

Bradley A. Evanoff, MD 86, HS 89
Justin D. Krogue

Naomi Y. Jiang
Laura J. Bierut, MD 87, HS 91

Stanley M. Wald, MD 46
Austin J. Wesevich

ROBERT BOSTON

Michael Crowder, MD/PhD 89
Kevin T. Baumgartner
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2011–12
Distinguished Alumni
Scholarship Program
Honorees and Scholars
The Distinguished Alumni Scholarship
Program awards four-year, full-tuition
scholarships named in honor of
esteemed alumni of the School of
Medicine. Honorees are selected based
on outstanding citizenship and leadership, and scholars are chosen for their
exceptional academic record and character. In addition to these four students,
there are 86 others that receive funding
in part through unrestricted gifts to the
Annual Fund.
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memorial

BY MICHELE HOEFT

“Bo” Koster’s love of science
inspires contributions of others

Scientific
spirit soars
The Joseph C. Koster
Memorial Fund has helped
support activities associated
with an annual Koster Memorial
Lecture, presented by the Center for the
Investigation of Membrane Excitability
Diseases (CIMED) and the Department of
Cell Biology and Physiology. The lecture
series showcases the significant contributions to the understanding of membrane
excitability and associated diseases.
The 2011 lecture featured Harvard
Medical School neurobiologist Gary Yellen,
PhD, who led a seminar titled “Reverse
Engineering Epilepsy Therapy: Exploring
Metabolism and Excitability.” The first
two lectures were met with great
success, an indicator that future
lectures will be highly anticipated.
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One person can make a difference in the world. Some people
accomplish this through their work, some through their personal
relationships, and some through their commitment to the community. Joseph C. “Bo” Koster, PhD, managed to make a difference in
each of those aspects through his life’s work advancing medicine.
A St. Louis native, avid runner and bird watcher, Koster began
working in the Department of Cell Biology and Physiology at
Washington University School of Medicine as a graduate student.
He turned down postdoctoral opportunities on the West Coast
in order to stay within the department and work with Colin G.
Nichols, PhD, the Carl F. Cori Professor.
Koster loved everything about science and being in the lab; his
work set a high standard. In his later research, he discovered one
of the fundamental causes of neonatal diabetes, a discovery that
led to a revolution in therapy, allowing many patients to switch
their therapy from insulin shots to pills.
His findings made a difference in the lives of many.
Sadly, he passed away in February, 2010. His important research
findings remain alive in the work of his research partner Nichols
as he continues their groundbreaking work.
“Bo was an important member of our departmental community,” says Philip D. Stahl, PhD, professor emeritus and former
head of the Department of Cell Biology and Physiology. “He was
deeply and passionately engaged in his research and made the lab
his second home. He is missed.”
Koster’s life pursuit was medical research; his devotion to
this field led his uncle, Col. Charles R. Stribling III and his wife,
Winnie Runge-Stribling, to establish an endowed fund in their
nephew’s name. The Joseph C. Koster Memorial Fund has become
a lasting tribute to him, and it inspires other researchers to make
their own life-changing contributions to medical research.
Koster’s important work continues to be a focus for Nichols’ lab.
His family, brother R. Stribling Koster and sister Ann Antoniou,
hope that the medical discoveries initiated by their brother will
lead to better treatments for patients. Although Joseph C. “Bo”
Koster is no longer with us, he continues to make a difference in
the lives around us.

Winter 2011
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BY MICHELE HOEFT

Ongoing support
Farrell Family Research Fund to focus
on Alzheimer’s disease and dementia

David C. and Betty Farrell

D

avid C. and Betty Farrell are close
friends of Washington University
School of Medicine and have shown
their confidence and trust in the university in
myriad ways. Shortly after moving to St. Louis
in 1975 as president of May Department Stores
Co., Farrell and his wife spent time immersing
themselves in their local community. Through
(then-Chancellor) William H. Danforth, MD,
David Farrell became involved with Washington
University, eventually becoming a university
trustee. Since then, he has watched the university’s
extraordinary growth and excellence in research
for nearly four decades.
The Farrell’s trust and personal belief in the
university were made known early on when they
endorsed the decision of both of their sons —
Mark, LW 86, and David, LW 90 — to attend
the School of Law. As the years progressed,
their passion for the School of Medicine led
them to give remarkable gifts. When Farrell
retired as chairman and chief executive officer
of May Co., the couple, along with his former
employer, established the David C. and Betty
Farrell Distinguished Professorship in Medicine.
In 2005, through a lead naming gift, the Farrells
helped open the doors to the Farrell Learning and
Teaching Center (FLTC). The outstanding educational facility for medical students and faculty has
become a model for other institutions.
“With the opening of the Farrell Learning and
Teaching Center, the university took an exciting
outlook.wustl.edu

step forward in providing world-class medical
education,” says Larry J. Shapiro, MD, executive
vice chancellor for medical affairs and dean of the
School of Medicine. Today, the FLTC is the heart
and hub of the medical center, training and educating the best and brightest students in the world.
The Farrells’ support of the university hasn’t
slowed. Most recently, they have contributed to
the growth of the School of Medicine through
a $1 million gift to establish and endow the
Farrell Family Research Fund in the Department
of Neurology.
Not only will this endowed fund support
much-needed research in neurological disorders,
specifically Alzheimer’s disease and dementia, it
also will allow the School of Medicine to receive
an equal amount from the Danforth Foundation
for the Donald Danforth, Jr. Advanced Research
in Neurological Disorders Endowment Fund,
through the Danforth Foundation Challenge for
Neurological Disorders.
The Danforth Foundation Challenge was established with a gift from the Danforth Foundation to
support innovative research at the internationally
known Hope Center for Neurological Disorders.
Gifts like the Farrells’ that are received or
committed by December 31, 2013 — up to a total
of $10 million — will secure an equal amount
of endowment support from the Danforth
Foundation to support the Hope Center.
The Farrells felt it was important that they
contribute now. “Alzheimer’s disease has affected
my family, so I have a special interest in it,” says
David Farrell. “I’ve gotten to know Dr. John
Morris and his work in the field. The medical
school is without peers, and its partner,
BJC HealthCare, is an outstanding institution.”
The School of Medicine is honored to have
the dedicated support of two of St. Louis’ most
respected leaders, philanthropists and volunteers,
David C. and Betty Farrell.

Gifts like the Farrells’
that are received or
committed by December
31, 2013 — up to a total
of $10 million — will
secure an equal amount
of endowment support
from the Danforth
Foundation to support
the Hope Center.
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scholarships

Leading
the way

Kyle G. Jacobsen, Class of 2014, center, with Ronnie and Jay A. Kaiser, MD 72

Physicians committed to helping medical students finance their education
As co-chairs of the scholarship initiative committee and major donors to
Washington University School of Medicine, Jay A. Kaiser, MD 72, and
Gordon W. Philpott, MD 61, are as serious about attracting the best and
brightest talent to the school as they are about helping medical students
fulfill their dreams without the burden of enormous debt.
The two physicians, who both serve on the school’s National Council,
Scholarships make education
more accessible to all students.
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share a commitment to today’s medical students and their chosen profession.
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BY HILARY DAVIDSON
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Jay A. Kaiser, MD 72: A need to give back

Debt can limit career choices for physicians

Kaiser founded and is president of California
Advanced Imaging Medical Associates located in
the San Francisco Bay area.
But Kaiser, who remembers being a student
fresh out of college who needed a leg up, came
from much humbler beginnings.
“My father was a coal miner. I had no money,”
he recalls. “To attend a medical school the quality of Washington University School of Medicine
wouldn’t have been possible without scholarships
and loans.”
Kaiser credits his professional success not only
to his medical education, but also to the culture of
excellence and constant learning that he internalized during his training in St. Louis.
“Everything I’ve achieved is due to the education I received at Washington University,” he says.
Because of that, Kaiser and his wife, Ronnie,
began donating to the university when he entered
private practice. They have a named endowed
scholarship and contribute to the Class of 1972
scholarship fund.
“It’s important that people from all economic
levels of our society have the opportunity to attend
medical school,” he says. “Who better to understand that than physicians?”

Kaiser and Philpott view scholarships as a way
to help young physicians avoid crushing debt,
freeing them to make career choices based on
their unique interests.
“The students ought to always be able to make
a decision (about specialty) based on their heart,”
Kaiser says. “If you want to train physicians to go
into the less highly paid specialties, you have to
support them.”
Philpott, who spent his career as a faculty
member, worries that excessive debt load may
prevent some talented individuals from pursuing
careers in academic medicine, robbing the future
of great teachers and investigators.
“Keeping people in the teaching and academic
world is one of my personal aims,” says Philpott.

ROBERT BOSTON

Philpott, emeritus professor of surgery, has always
felt the need to give back to the school where he
received his education.
Shortly after becoming a faculty member, he
convinced his mother to set up a scholarship fund
for students. Since then, he’s set up an endowed
scholarship, donated to annual scholarships and,
with Kaiser, is leading the effort to bring in more
money for medical students.
But there was one aspect of giving that Philpott
never anticipated: how much enjoyment he would
derive from getting to know the medical students.
“Creating and participating in these scholarships is not only a good thing to do, it’s actually
fun,” he says. “It keeps us connected with the
students and the school.”
He and his wife, Susie, stay in touch with their
scholars, both past and present. Current Philpott
scholar Marshall C. Strother, a second-year medical
student, calls the couple “wonderful” and says he
enjoys spending time with them.
The feeling is mutual.
“The students are so good; they’re bright and
hard-working,” says Philpott. “We are proud to be
part of the school’s ongoing scholarship efforts.”
outlook.wustl.edu
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Gordon W. Philpott, MD 61: The fun of giving

“If students are in debt, they feel compelled to pick
a field, such as the clinical option, that is more
financially rewarding. I’m worried that teachers
are going to be hard to find.”
Because cost has become such a critical factor
in how students choose a medical school, scholarships help attract the very best students.
“Every student who is considering enrolling
at Washington University School of Medicine has
already shown a commitment to excellence and a
desire to keep learning,” says Kaiser. “To continue
to attract that high quality of student into the
program, we need to support them.”

Susie and Gordon W. Philpott,
MD, with their students, from
lower left: Salil H. Desai
(Class of 2012), Douglas J.
Dearth Jr. (Class of 2013),
S. Hassan Akbari (Class of
2012), and Marshall C.
Strother (Class of 2014)

for more information, please visit

scholarshipinitiative.wustl.edu
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classnotes
1940 S

1970 S

2000 S

Charles Fullenwider, MD 43
Fullenwider is a retired ophthalmologist.
He has traveled to Egypt, West Africa
and Turkey in the past five years. He also
enjoys reading, gardening and being a
member of the Rotary Club.

Robert M. Galatzer-Levy, MD 71
Galatzer-Levy, a child and adolescent
psychoanalyst, is on the faculty of the
Chicago Institute for Psychoanalysis and
the University of Chicago. His latest interests include chaos theory and false
confessions. The second edition of his
book, The Scientific Basis of Child Custody
Decisions, was published in 2009.

Scott Lovitch, MD 07
Lovitch recently completed his residency
in pathology and fellowship in hematopathology, and he is signing out six weeks
per year on the hematopathology service
at Brigham. He is also doing postdoctoral
research in immunology in Arlene Sharpe’s
(MD, PhD) lab and teaching at Harvard
Medical School. He and his fiancée are
planning a July 2012 wedding.

Elliot D. Luby, MD 49
Luby is professor emeritus of psychiatry
and law at Wayne State University and
past president of the Michigan Psychiatric
Society. The Elliot D. Luby, MD Endowed
Professorship at Wayne State University
is currently held by Manuel Tancer, MD.
Luby’s daughter, Joan L. Luby, MD, is a
professor of child psychiatry at
Washington University School of Medicine.

1950 S
James Cunningham, MD 51
Cunningham served in Afghanistan and
Africa as a visiting orthopedic surgeon
with a humanitarian organization.
James Cutter, MD 51
Cutter has been an avid hiker, backpacker
and photographer throughout many state
and national parks in California. He has
one son who is an anesthesiologist and
one daughter and three granddaughters
who are registered nurses.
Brent Parker, MD 52
Parker and his wife, Molly, took a driving
trip to Glacier National Park. They sing
in their church choir and attend all of
the symphony concerts. He likes to hike
in the mountains, lead nature walks in
the Garden of the Gods, and play tennis.
Parker is hopeful that he will be able to
attend his 60th reunion in 2012.

1960 S
John S. Douglas Jr., MD 67
Douglas is professor of medicine and
director of interventional cardiology and
the cardiac catheterization laboratory at
Emory University Hospital in Atlanta GA.
He enjoys work, golf, gardening and his
four grandsons.
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Mark Stitham, MD 75
Stitham continues to be active in his
avocation of acting, appearing in two
episodes of the television show “Lost.”

1980 S
Ralph Glasser, MD 81
Glasser is a partner at Associated
Anesthesiologists of Springfield IL, a
clinical professor at Southern Illinois
University in Springfield, and the immediate past-president of the Illinois Society of
Anesthesiologists. He has flown for seven
years as the #5 wingman and lead acrobatics pilot with the Trojan Horsemen Airshow
Team. Other pastimes include family travel,
scuba diving with his daughter, and
collecting Alfa Romeo Spider roadsters.

1990 S
Maral Kibarian Skelsey, MD 91, HS 95
Skelsey is director of dermatologic surgery at Georgetown University Medical
Center in Washington DC, and has
been appointed a consultant to the
Food and Drug Administration (FDA)
Committee for (Medical) Devices and
Radiological Health. She also serves as
assistant clinical professor of dermatology at Georgetown University School of
Medicine and conducts ongoing research
related to skin cancer. Skelsey also directs
the Dermatologic Surgery Center of
Washington in Chevy Chase MD, an
outpatient surgical center and
diagnostic laboratory that specializes in
Mohs micrographic surgery.

Anjali Gopalan, MD 08
Gopalan has been selected as a 2012
Robert Wood Johnson Foundation (RWJF)
Clinical Scholar. She will begin her fellowship in the fall of 2012 at the University
of Pennsylvania and the Veterans Affairs
Medical Center.
Sushant Punjaram Kale, MD, MPH, HS 09
Kale recently joined the faculty at
Southern Illinois University School of
Medicine as an assistant professor of
neurology. He also is a member of SIU
HealthCare, the medical school’s practice
group, and director of St. John’s Hospital
Stroke Center. He is married to Shubhangi
Peche, has one child, and has been
published in several professional journals.

I M
Ruth Jensen, NU 37
Jensen died on June 28, 2011. She was
the wife of St. Louis physician J.E. Jensen
Sr., MD. She was active in Girl Scouts,
the Missouri Baptist Auxiliary, and Third
Baptist Church. She is survived by three
children, six grandchildren and four
great-grandchildren.
Dorothy M. Kraft, NU 40, NU 42
Kraft, 92, died on May 17, 2011. She
donated her body to Washington
University School of Medicine.
Walter J. Kennedy Jr., MD 43
Kennedy, 92, died on March 20, 2011. After
earning his medical degree, he served in
the U.S. Army for two years in Omaha NE
and at Shick General Hospital in Clinton IA.
He was honored by the Yakima County
Medical Society, receiving a Fifty Year
Winter 2011

Service Award, and at 80 years of age he
tested for and received special certification in pediatric neonatology. Kennedy
was a Diplomate of the American Board
of Pediatrics and served numerous other
organizations throughout his career.
Henry Uhlemeyer III, LA 39, MD 43, HS
Uhlemeyer died on August 29, 2011. He
attended Washington University for his
undergraduate and medical educations
and then stayed with the university for
medical residency training.
William H. Weiss, MD 46
Weiss died on June 27, 2011. After earning his medical degree, he did a residency
at the Cleveland Clinic where he trained
to become an ear, nose and throat physician. He was most proud of “never losing
a postsurgical patient or being named in
a lawsuit.”
Ann Fee, NU 47
Fee, 86, died on June 20, 2011. While
in nursing school, she met her future
husband, Wesley S. Fee, MD 44, HS 51.
After raising their children, they retired,
sold their cattle ranch on the banks of the
Tanque Verde, reluctantly surrendered
their season tickets to Wildcat games, and
volunteered with the Indian Health Service
in Alaska for 13 years. Retirement allowed
them to pursue their love of traveling,
hunting, scuba diving and fishing. Fee was
a civic leader and volunteer, supporting
numerous community organizations.
Herluf G. Lund Sr., MD 49
Lund, 94, died on August 30, 2011. He
earned both his undergraduate and medical degrees at Washington University and
later served in the U.S. Army Medical
Corps at Fort Gordon GA. He worked on
the medical staffs of many area hospitals,
including St. Anthony’s Hospital and
Lutheran Hospital, where he also served as
president of the medical staff. The Missouri
State Medical Association recognized him
with the 50 Year Membership Award.
He was an avid golfer and a longtime
member of the Old Warson Country Club.
Albert Peterman, MD 52
Peterman, 85, died on May 30, 2011.
Following U.S. Army service during World
War II, he became committed to having a
career that focused on saving lives. After
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earning his medical degree, he was a
resident at Philadelphia General Hospital
where he met his wife, Nancy DeWitt,
the chief nurse in the emergency room.
During training, he discovered a passion
for neurology, and he later became chief
of the department and a clinical instructor
in neurology at Stanford University School
of Medicine. After practicing for more than
four decades, he retired in 2001. This first
retirement did not last long once he realized that golf, travel and the occasional
Monopoly tournament did not satisfy his
needs. He entered the workforce again,
evaluating disability claims submitted to
the Social Security Administration, a job
he held until his final retirement in 2010.
Kurt D. Burns, DE 53
Burns, 83, died on July 24, 2011. Following graduation, the Naval Reserve called
him to active duty, where he served as a
lieutenant stationed at Camp Pendleton
in San Diego CA.
Elden H. Mecham, DE 60
Mecham, 82, died on May 20, 2011. He
practiced for 32 years in Salt Lake City UT.
He loved reading, history, drawing, model
airplanes, classical music, ice cream and
his wife’s famous pie. He and his wife,
Mary, celebrated 55 years of marriage.
Wallace M. Kameoka, DE 61
Kameoka, 79, of Mililani HI, died on
April 30, 2011. He was a U.S. Army
veteran and was retired from practice.

F
Harold R. Schreiber, LA 40, DE 47
Schreiber died on Feb. 10, 2011. He
completed his undergraduate studies at
Washington University, then served in the
U.S. Army. After completing his tour, he
graduated from Washington University
School of Dental Medicine and became
a Diplomate of the American Board of
Periodontology. He continued to serve
his country as a periodontal consultant to
the U.S. Fifth Army, Scott Air Force Base
and the Veterans Administration. He held
several positions at Washington University
School of Dental Medicine. Most recently,
he served as a clinical professor in the

Graduate Periodontics Department at the
Saint Louis University Center for Advanced
Dental Education. He was recognized
in 2000 with the Gold Medal Award
by the Greater St. Louis Dental Society
and, in 2001, was awarded the Lifetime
Achievement Award from the American
College of Dentists.
J. Neal Middelkamp, MD 48
Middelkamp, professor emeritus of pediatrics, died on Nov. 2, 2011. He was 86.
He spent his entire career at Washington
University Medical Center, from residency
at St. Louis Children’s Hospital to joining
the faculty in the medical school’s
Department of Pediatrics. He served as
director of the department’s Division of
Infectious Diseases and the Division of
Ambulatory Pediatrics, and he was the
pediatric clerkship course master for 40
years. He also served on the Residency
Review Committee for pediatrics and was
active in the Office of Graduate Medical
Education. He was a member of the
American Board of Pediatrics, including
the group’s board of directors, and in
1988 he served as the board’s chairman.
In 1958, Middelkamp was a fellow of the
National Foundation/March of Dimes
and began to study viral diseases affecting children. He received the School of
Medicine’s Alumni Award in 1988 and its
Distinguished Alumni Scholarship in 1993.
He received St. Louis Children’s Hospital’s
Distinguished Physician Award in 1997.
Middelkamp and his wife, Lois, also established the J. Neal and Lois Middelkamp
Visiting Professorship in Pediatrics to
support a pediatric lectureship in infectious diseases and advances in pediatric
education for medical students, residents
and pediatricians. He is survived by his
wife; four children: Sharon Belcher, Steven
Middelkamp, Susan Crean and Scott
Middelkamp; a sister; nine grandchildren
and two great-grandchildren.

If you wish to make a tribute in honor
of any of the above alumni or faculty,
please contact: Pamela Buell, Washington
University Medical Alumni and Development,
Campus Box 1247, 7425 Forsyth Blvd., St. Louis
MO 63105, (314) 935-9691.
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Opening Doors to the Future

The Scholarship Initiative for
Washington University School of Medicine

I

n order to remain affordable for our students and to continue to
compete with the nation’s strongest medical schools, the School
of Medicine has placed even greater emphasis on philanthropic

support of scholarships. For more than eight decades, alumni and
friends have carried on a tradition of scholarship support.
The cost of a medical education results in an unfair debt load
for our students, and we are compelled to alleviate this burden.

Scholarships ensure
that deserving
students do not miss
the opportunity for
a premier education.

Scholarships are the key to allowing future generations of students to
pursue a career path based on passion, not on potential income.
You may name your scholarship in memory of a loved one, in tribute to a friend, or in honor of yourself,
your family, or your company. In the fall, a student will be selected to receive your scholarship and you will be notified
with information about the student. You also will receive an invitation to the annual scholarship dinner.
PHONE

( 314 ) 935 - 9691

EMAIL

meddev@wustl.edu

WEB

scholarshipinitiative.wustl.edu

Surveying
the brain

Horsley-Clarke Stereotaxic Instrument

ROBERT BOSTON

First cited in Horsley, V. and Clarke R.H. The Structure
and Functions of the Cerebellum Examined by a New
Method. Brain, v. 31, 1908, pp. 45–124.
The device, made by Palmer and Company, London, in
1908, was recently on loan to Becker Medical Library
from History & Special Collections for the Sciences,
Library Special Collections, UCLA Louis M. Darling
Biomedical Library. Exhibition made possible by the
Barbara and Leon Rootenberg Endowment Fund at the
UCLA Library. Restoration by David Kopf Instruments.

One hundred years ago the three-dimensional brain remained an
undiscovered territory. Mapping that territory required precision,
and a device that showed great promise was described by Sir Victor
Horsley, a pioneer in neurosurgery, in a 1908 journal article. That
year, a London-based instrument company made the second such
device for Ernest Sachs, MD, a young doctor who was studying with
Horsley. In 1910, the School of Medicine’s Department of Surgery
recruited Sachs to St. Louis to develop a neurosurgery program.
The Department of Neurological Surgery — which celebrated
the 100th anniversary of neurosurgery at the School of Medicine
in September — is internationally known for its leadership in
groundbreaking basic and clinical research, dedication to patient
care, and training of outstanding residents and fellows. For more
information, please visit neurosurgery.wustl.edu.
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Touchdown

2 Washington University School of Medicine

With the onset of cooler weather comes the
southward migration of the Monarch butterfly. On its way to warmer
climes, this insect stopped to rest atop flora blooming in the plaza of
the medical center’s newest research facility, the BJC Institute of Health
at Washington University School of Medicine.
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